# FDA 483 - WuXi Advanced Therapies - April 17, 2015

Source: https://www.globalkeysolutions.net/records/483/wuxi-advanced-therapies/21c96ee1-b2af-4f88-91e7-bebf470f9a36

> FDA 483 for WuXi Advanced Therapies on April 17, 2015. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: WuXi Advanced Therapies
- Inspection Date: 2015-04-17
- Product Type: Drugs
- Office Name: Philadelphia District Office

## Related Documents

- [EIR - Unknown Date](https://www.globalkeysolutions.net/records/eir/wuxi-advanced-therapies/5911391f-9b97-4e59-a904-139532178630)
- [EIR - Unknown Date](https://www.globalkeysolutions.net/records/eir/wuxi-advanced-therapies/73d8fd41-c508-487d-adb8-e3213defbba1)

## Related Officers

- [Consumer Safety Officer at FDA U.S. Food and Drug Administration](https://www.globalkeysolutions.net/people/ko-u-min/9bb5f33e-857b-4c6f-a550-fdb439760e30)
- [Consumer Safety Officer ](https://www.globalkeysolutions.net/people/anastasia-m-shields/a22b8d52-e3f9-4e61-aa3f-6f03ff2f59df)
- [PreApproval Manager](https://www.globalkeysolutions.net/people/gayle-s-lawson/cd8061de-f089-408c-bbfc-c7c7a5635dd7)

Company: https://www.globalkeysolutions.net/companies/wuxi-advanced-therapies/2d12016c-2b9d-4b5e-91a8-4f8af5bee2e1

Office: https://www.globalkeysolutions.net/offices/philadelphia-district-office/c5ec7398-b3d5-4125-9793-fb7b972578d8